Variant report
Variant | esv3323025 |
---|---|
Chromosome Location | chr2:78947494-78948842 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs185635164 | chr2:78947498-78947499 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs531303567 | chr2:78947515-78947516 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs551422732 | chr2:78947549-78947550 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs115516016 | chr2:78947558-78947559 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs140839117 | chr2:78947581-78947582 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs372897653 | chr2:78947585-78947586 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs144374135 | chr2:78947588-78947589 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs151197901 | chr2:78947597-78947598 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs190095874 | chr2:78947643-78947644 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs373371521 | chr2:78947648-78947649 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs570182752 | chr2:78947721-78947722 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs538738414 | chr2:78947765-78947766 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs71385231 | chr2:78947823-78947824 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs374266800 | chr2:78947824-78947825 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs140353777 | chr2:78947838-78947839 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs11693043 | chr2:78947840-78947841 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs34399313 | chr2:78947842-78947843 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
18 | rs34696321 | chr2:78947843-78947844 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs554846311 | chr2:78947844-78947845 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs149956297 | chr2:78947855-78947856 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs376376898 | chr2:78947892-78947893 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs544041508 | chr2:78947926-78947927 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs181563104 | chr2:78947962-78947963 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs576119429 | chr2:78947971-78947972 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs113894122 | chr2:78948049-78948050 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs112855131 | chr2:78948119-78948120 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs527284771 | chr2:78948174-78948175 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs140782120 | chr2:78948206-78948207 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs561274151 | chr2:78948218-78948219 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs529945313 | chr2:78948260-78948261 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs549979465 | chr2:78948272-78948273 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs569737811 | chr2:78948275-78948276 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs538414520 | chr2:78948287-78948288 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs201222856 | chr2:78948370-78948371 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs565790859 | chr2:78948372-78948373 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs576897416 | chr2:78948401-78948402 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs192032960 | chr2:78948447-78948448 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs184160838 | chr2:78948471-78948472 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs537327283 | chr2:78948497-78948498 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs557597105 | chr2:78948530-78948531 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs577386162 | chr2:78948532-78948533 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs144618408 | chr2:78948541-78948542 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs74533383 | chr2:78948569-78948570 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs188707895 | chr2:78948601-78948602 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs541077708 | chr2:78948634-78948635 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs78660898 | chr2:78948642-78948643 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs530038512 | chr2:78948650-78948651 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs80230111 | chr2:78948707-78948708 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs75916070 | chr2:78948708-78948709 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs543370161 | chr2:78948713-78948714 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Chronic lymphocytic leukemia | 21546498 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Adrenal tumor | 17535989 | CNVD |
Breast cancer | 21264507 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Medulloblastoma | 17522785 | CNVD |
Cancer | 23418310 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Breast cancer | 17603634 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ependymoma | 16718352 | CNVD |
Prostate cancer | 18632612 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Autism | 17483303 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Medulloblastoma | 20607354 | CNVD |
Autism | 22495311 | CNVD |
Autism | 18522746 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Lung cancer | 18438408 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Mental retardation | 17124404 | CNVD |
Basal cell lymphoma | 19029149 | CNVD |
Diffuse large b-cell lymphoma | 19029149 | CNVD |
Cancer | 17440070 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Attention deficit hyperactivity disorder | 21324949 | CNVD |
Breast cancer | 16272173 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:78946800-78948600 | Weak transcription | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
2 | chr2:78948600-78948800 | Enhancers | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |